ExodusPoint Capital Management LP Has $9.16 Million Stock Holdings in UiPath Inc. (NYSE:PATH)

ExodusPoint Capital Management LP grew its stake in shares of UiPath Inc. (NYSE:PATH) by 45.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 720,423 shares of the company’s stock after purchasing an additional 223,669 shares during the quarter. ExodusPoint Capital Management LP owned about 0.13% of UiPath worth $9,157,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Trexquant Investment LP bought a new stake in shares of UiPath in the 4th quarter valued at about $15,611,000. HighPoint Advisor Group LLC acquired a new position in UiPath during the fourth quarter worth approximately $311,000. Franklin Resources Inc. raised its stake in UiPath by 1,245.4% in the fourth quarter. Franklin Resources Inc. now owns 136,690 shares of the company’s stock valued at $1,737,000 after buying an additional 126,530 shares during the period. Arrowstreet Capital Limited Partnership acquired a new stake in shares of UiPath in the fourth quarter valued at approximately $5,776,000. Finally, Pictet Asset Management Holding SA increased its holdings in shares of UiPath by 14.3% during the 4th quarter. Pictet Asset Management Holding SA now owns 67,861 shares of the company’s stock worth $863,000 after acquiring an additional 8,497 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on PATH. UBS Group reduced their price objective on shares of UiPath from $14.00 to $10.00 and set a “sell” rating for the company in a research report on Thursday, March 13th. Wells Fargo & Company decreased their price target on shares of UiPath from $13.00 to $11.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 13th. Royal Bank of Canada reissued a “sector perform” rating and issued a $13.00 price target on shares of UiPath in a report on Wednesday, March 26th. Mizuho reduced their price objective on UiPath from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Thursday, March 13th. Finally, Barclays lowered their target price on UiPath from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $13.62.

UiPath Stock Down 2.2 %

Shares of UiPath stock opened at $10.04 on Friday. UiPath Inc. has a 12-month low of $9.50 and a 12-month high of $21.90. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of -62.72 and a beta of 1.00. The firm’s 50-day moving average price is $12.58 and its two-hundred day moving average price is $12.97.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.